Pulmonary Lesion Assessment: Comparison of Whole-Body Hybrid MR/PET and PET/CT Imaging—Pilot Study
- 1 August 2012
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 264 (2), 551-558
- https://doi.org/10.1148/radiol.12111942
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Negative Predictive Value of Positron Emission Tomography and Computed Tomography for Stage T1-2N0 Non–Small-Cell Lung Cancer: A Meta-AnalysisClinical Lung Cancer, 2012
- Predicting prolonged air leak after standard pulmonary lobectomy: Computed tomography assessment and risk factors stratificationThe Surgeon, 2011
- Monitoring Response to Antiangiogenic Therapy in Non–Small Cell Lung Cancer Using Imaging Markers Derived from PET and Dynamic Contrast-Enhanced MRIJournal of Nuclear Medicine, 2010
- Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer stagingJournal of Magnetic Resonance Imaging, 2010
- Impact of 18F-FDG PET on Treatment Strategy and 3D Radiotherapy Planning in Non–Small Cell Lung Cancer: A Prospective Multicenter StudyAmerican Journal of Roentgenology, 2010
- 18F-FDG Uptake in Lung, Breast, and Colon Cancers: Molecular Biology Correlates and Disease CharacterizationJournal of Nuclear Medicine, 2009
- Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography☆European Journal of Cardio-Thoracic Surgery, 2009
- EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentaryEuropean Journal Of Cancer, 2009
- Positron Emission Tomography/Computed Tomography and Whole-Body Magnetic Resonance Imaging in Staging of Advanced Nonsmall Cell Lung Cancer???Initial ResultsInvestigative Radiology, 2008
- The Additional Value of FDG PET Imaging for Distinguishing N0 or N1 From N2 Stage in Preoperative Staging of Non-small Cell Lung Cancer in Region Where the Prevalence of Inflammatory Lung Disease Is HighClinical Nuclear Medicine, 2007